LeadIQ logo
Learn more at LeadIQ.com

Insights

Innovative Rare Disease Focus Orphazyme specializes in developing therapies for neurodegenerative orphan diseases, indicating a target market of healthcare providers and organizations focused on rare disease treatments and specialized patient communities.

Recent Asset Transaction The sale of assets to Zevra Therapeutics and KemPharm highlights Orphazyme's strategic shift towards commercialization and potential partnership opportunities with organizations involved in similar rare disease pipelines.

Global Expansion Strategy With offices across Denmark, Switzerland, and the US, Orphazyme presents opportunities to engage with healthcare markets in North America and Europe, enabling sales tailored to regional regulatory and medical communities.

Late-Stage Pipeline Having a late-stage drug pipeline suggests readiness for market entry, creating potential sales channels for medical providers, pharmacies, and healthcare systems preparing for upcoming therapies.

Financial and Market Position With substantial funding of over 100 million USD but limited current revenue, Orphazyme is seeking strategic partnerships and collaborations that can facilitate market access and accelerate commercial growth.

Orphazyme A/S Tech Stack

Orphazyme A/S uses 8 technology products and services including Google Cloud, IBM, Underscore.js, and more. Explore Orphazyme A/S's tech stack below.

  • Google Cloud
    Infrastructure As A Service
  • IBM
    IT
  • Underscore.js
    Javascript Libraries
  • jQuery UI
    Javascript Libraries
  • jQuery Migrate
    Javascript Libraries
  • Yoast SEO
    Search Engines
  • Adobe Fonts
    Web Fonts
  • Twitter
    Widgets

Media & News

Orphazyme A/S's Email Address Formats

Orphazyme A/S uses at least 1 format(s):
Orphazyme A/S Email FormatsExamplePercentage
First.Last@orphazyme.comJohn.Doe@orphazyme.com
45%
Last@orphazyme.comDoe@orphazyme.com
5%
First.Last@orphazyme.comJohn.Doe@orphazyme.com
45%
Last@orphazyme.comDoe@orphazyme.com
5%

Frequently Asked Questions

What is Orphazyme A/S's phone number?

Minus sign iconPlus sign icon You can contact Orphazyme A/S's main corporate office by phone at
+45-70-70-2****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Orphazyme A/S's stock symbol?

Minus sign iconPlus sign iconOrphazyme A/S is a publicly traded company; the company's stock symbol is ORPHY.

What is Orphazyme A/S's official website and social media links?

Minus sign iconPlus sign iconOrphazyme A/S's official website is orphazyme.com and has social profiles on LinkedIn.

What is Orphazyme A/S's SIC code NAICS code?

Minus sign iconPlus sign iconOrphazyme A/S's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Orphazyme A/S have currently?

Minus sign iconPlus sign iconAs of December 2025, Orphazyme A/S has approximately 108 employees across 2 continents, including EuropeNorth America. Key team members include Executive Director, Payer Engagement: T. D.Statistics Specialist: T. H.: C. B.. Explore Orphazyme A/S's employee directory with LeadIQ.

What industry does Orphazyme A/S belong to?

Minus sign iconPlus sign iconOrphazyme A/S operates in the Biotechnology Research industry.

What technology does Orphazyme A/S use?

Minus sign iconPlus sign iconOrphazyme A/S's tech stack includes Google CloudIBMUnderscore.jsjQuery UIjQuery MigrateYoast SEOAdobe FontsTwitter.

What is Orphazyme A/S's email format?

Minus sign iconPlus sign iconOrphazyme A/S's email format typically follows the pattern of First.Last@orphazyme.com. Find more Orphazyme A/S email formats with LeadIQ.

How much funding has Orphazyme A/S raised to date?

Minus sign iconPlus sign icon As of December 2025, Orphazyme A/S has raised $109M in funding. The last funding round occurred on Feb 07, 2020 for $109M.

When was Orphazyme A/S founded?

Minus sign iconPlus sign iconOrphazyme A/S was founded in 2009.

Orphazyme A/S

Biotechnology ResearchDenmark51-200 Employees

Orphazyme is a global biopharmaceutical company, headquartered in Denmark, with a rapidly growing presence in the United States. We are pioneering a new kind of treatment, applying our specialized expertise to bring innovative therapies to patients with neurodegenerative orphan diseases. With a late-stage drug pipeline, we are relentless in our commitment to advancing treatments and making a profound impact for those touched by these rare, serious diseases.

Today we are listed on Nasdaq Copenhagen (TICKER: ORPHA.CO) and Nasdaq U.S. (TICKER: ORPH), and are expanding our global presence with offices in Denmark, Switzerland, and our US headquarters in Chicago.

See our community guidelines: bit.ly/3uapRYr

Section iconCompany Overview

Phone number
+45-70-70-2****
Website
orphazyme.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
ORPHY
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2009
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $109M

    Orphazyme A/S has raised a total of $109M of funding over 7 rounds. Their latest funding round was raised on Feb 07, 2020 in the amount of $109M.

  • $1M

    Orphazyme A/S's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $109M

    Orphazyme A/S has raised a total of $109M of funding over 7 rounds. Their latest funding round was raised on Feb 07, 2020 in the amount of $109M.

  • $1M

    Orphazyme A/S's revenue is estimated to be in the range of $1M

Company Leadership

  • Stylized image of a person
    T. D.
    Executive Director, Payer Engagement
    Phone icon
    Mobile Phone
  • Stylized image of a person
    T. H.
    Statistics Specialist
    Phone icon
    Mobile Phone
  • Stylized image of a person
    C. B.
    Phone icon
    Mobile Phone
  • Stylized image of a person
    K. M.
    Phone icon
    Mobile Phone

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.